Results 41 to 50 of about 838,175 (338)

Antitumor Activity of Crizotinib in Lung Cancers Harboring a MET Exon 14 Alteration

open access: yesNature Medicine, 2019
MET exon 14 alterations are oncogenic drivers of non-small-cell lung cancers (NSCLCs)1. These alterations are associated with increased MET activity and preclinical sensitivity to MET inhibition2.
A. Drilon   +20 more
semanticscholar   +1 more source

From Order to Chaos: Publication, Synthesis and the Dissemination of Data in a Digital Age

open access: yesInternet Archaeology, 1999
In the past, the provision of authoritative, interpretative, syntheses is what archaeologists sought through publication. Now the first real challenge of the digital age has been to balance this trend and in contrast to archaeological practice over the ...
Vince Gaffney , Sally Exon
doaj   +1 more source

FreePSI: an alignment-free approach to estimating exon-inclusion ratios without a reference transcriptome. [PDF]

open access: yes, 2017
Alternative splicing plays an important role in many cellular processes of eukaryotic organisms. The exon-inclusion ratio, also known as percent spliced in, is often regarded as one of the most effective measures of alternative splicing events.
Jiang, Tao   +4 more
core   +1 more source

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

open access: yesSignal Transduction and Targeted Therapy, 2019
Inframe insertions of three or more base pairs in exon 20 of the epidermal growth factor receptor (EGFR) gene were among the first EGFR mutations to be identified as oncogenic drivers in non-small cell lung cancer (NSCLC).
S. Vyse, Paul H. Huang
semanticscholar   +1 more source

Improved ontology for eukaryotic single-exon coding sequences in biological databases [PDF]

open access: yes, 2018
Indexación: Scopus.Efficient extraction of knowledge from biological data requires the development of structured vocabularies to unambiguously define biological terms. This paper proposes descriptions and definitions to disambiguate the term 'single-exon
Clausen, P.   +4 more
core   +2 more sources

Synthetic polypeptides using a biologic as a reference medicinal product – the European landscape of regulatory approvals

open access: yesFrontiers in Medicine
Recent advances in synthetic drug manufacturing have introduced a new dynamic to the European regulatory system, with chemically synthesized polypeptide products using biological originator products as their reference medicine.
Kevin Klein   +2 more
doaj   +1 more source

Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation. [PDF]

open access: yes, 2019
PKM2 is a key metabolic enzyme central to glucose metabolism and energy expenditure. Multiple stimuli regulate PKM2's activity through allosteric modulation and post-translational modifications.
Chen, Tsan-Jan   +11 more
core   +3 more sources

Novel deletions causing pseudoxanthoma elasticum underscore the genomic instability of the ABCC6 region [PDF]

open access: yes, 2010
Mutations in ABCC6 cause pseudoxanthoma elasticum (PXE), a heritable disease that affects elastic fibers. Thus far, >200 mutations have been characterized by various PCR-based techniques (primarily direct sequencing), identifying up to 90% of PXE-causing
Chassaing, N   +9 more
core   +2 more sources

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

open access: yesJournal of Biological Chemistry, 1991
Vascular endothelial growth factor (VEGF) is an apparently endothelial cell-specific mitogen that is structurally related to platelet-derived growth factor.
E. Tischer   +6 more
semanticscholar   +1 more source

A SspI PCR-RFLP detecting a silent allele at the goat CSN2 locus [PDF]

open access: yes, 2005
The comparison between the cDNA sequence obtained and the published sequences of the goat CSN2 alleles showed a new single nucleotide polymorphism (SNP) (transition C-T) at the 180th nucleotide of the ninth exon.
COSENZA, GIANFRANCO   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy